Catalysts for $OCUL
14 tracked
Aug 5, 2026
earnings
OCULAR THERAPEUTIX, INC earnings
OCULAR THERAPEUTIX, INC
→
May 5, 2026
earnings
OCULAR THERAPEUTIX, INC earnings
OCULAR THERAPEUTIX, INC
→
Mar 17, 2026
approval
TOBRADEX ST (DEXAMETHASONE) — FDA approval
OCULAR THERAPEUTIX, INC
→
Jan 14, 2026
recall
Imprimis NJOF, LLC recall (Cls II)
OCULAR THERAPEUTIX, INC
→
Jan 14, 2026
recall
Imprimis NJOF, LLC recall (Cls II)
OCULAR THERAPEUTIX, INC
→
Jun 25, 2025
recall
Umary-USA.com recall (Cls I)
OCULAR THERAPEUTIX, INC
→
Jun 25, 2025
recall
Umary-USA.com recall (Cls I)
OCULAR THERAPEUTIX, INC
→
Jan 15, 2025
recall
Buy-Herbal recall (Cls I)
OCULAR THERAPEUTIX, INC
→
Jan 8, 2025
recall
GNMart LLC recall (Cls I)
OCULAR THERAPEUTIX, INC
→
Aug 16, 2022
approval
TOBRADEX ST (DEXAMETHASONE) — FDA approval
OCULAR THERAPEUTIX, INC
→
Aug 16, 2022
approval
TOBRADEX ST (DEXAMETHASONE) — FDA approval
OCULAR THERAPEUTIX, INC
→
Aug 16, 2022
approval
TOBRADEX ST (DEXAMETHASONE) — FDA approval
OCULAR THERAPEUTIX, INC
→
Aug 3, 2010
approval
TOBRADEX ST (DEXAMETHASONE) — FDA approval
OCULAR THERAPEUTIX, INC
→
Feb 13, 2009
approval
TOBRADEX ST (DEXAMETHASONE) — FDA approval
OCULAR THERAPEUTIX, INC
→